Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126030293 | 12603029 | 3 | F | 20160812 | 20160915 | 20160728 | 20160919 | EXP | PHHY2016CO097432 | NOVARTIS | 70.83 | YR | F | Y | 58.00000 | KG | 20160919 | CN | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126030293 | 12603029 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 200 MG, BID | Y | 22068 | 200 | MG | CAPSULE | BID | |||||
| 126030293 | 12603029 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 200 MG, BID (IN THE MORNING AND AT NIGHT) | Y | 22068 | 200 | MG | CAPSULE | BID | |||||
| 126030293 | 12603029 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 126030293 | 12603029 | 4 | C | MOVIDOL | 2 | Unknown | PRN (ONLY WHEN SHE FEEL THE DISTURBANCE) | U | 0 | ||||||||||
| 126030293 | 12603029 | 5 | C | MOVIDOL | 2 | U | 0 | ||||||||||||
| 126030293 | 12603029 | 6 | C | MELOXICAM. | MELOXICAM | 1 | Unknown | PRN (ONLY WHEN SHE FEEL THE DISTURBANCE) | U | 0 | |||||||||
| 126030293 | 12603029 | 7 | C | MELOXICAM. | MELOXICAM | 1 | U | 0 | |||||||||||
| 126030293 | 12603029 | 8 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 500 MG, BID | U | 0 | 500 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126030293 | 12603029 | 1 | Chronic myeloid leukaemia |
| 126030293 | 12603029 | 3 | Product used for unknown indication |
| 126030293 | 12603029 | 4 | Limb discomfort |
| 126030293 | 12603029 | 5 | Dislocation of vertebra |
| 126030293 | 12603029 | 6 | Limb discomfort |
| 126030293 | 12603029 | 7 | Dislocation of vertebra |
| 126030293 | 12603029 | 8 | Arthralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126030293 | 12603029 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126030293 | 12603029 | Abdominal pain upper | |
| 126030293 | 12603029 | Cold sweat | |
| 126030293 | 12603029 | Decreased appetite | |
| 126030293 | 12603029 | Dehydration | |
| 126030293 | 12603029 | Drug intolerance | |
| 126030293 | 12603029 | Headache | |
| 126030293 | 12603029 | Nausea | |
| 126030293 | 12603029 | Peripheral coldness | |
| 126030293 | 12603029 | Platelet count decreased | |
| 126030293 | 12603029 | Rash generalised | |
| 126030293 | 12603029 | Weight decreased | |
| 126030293 | 12603029 | Yellow skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126030293 | 12603029 | 1 | 2010 | 0 | ||
| 126030293 | 12603029 | 2 | 20160706 | 20160830 | 0 |